Related Experiment Video
Updated: Nov 6, 2025

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
Acupuncture for Cancer-Related Anorexia: a Review of the Current Evidence
Wenli Liu1, Gabriel Lopez2, Santhosshi Narayanan2
1Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. wenliliu@mdanderson.org.
Acupuncture shows promise for cancer anorexia, but more research is needed. Current evidence is insufficient to confirm its effectiveness for improving appetite in cancer patients.
Area of Science:
- Oncology
- Integrative Medicine
- Traditional Chinese Medicine
Background:
- Cancer-related anorexia affects up to 70% of advanced cancer patients, posing a significant clinical challenge.
- Effective management of appetite loss in oncology is crucial for patient well-being and treatment adherence.
Purpose of the Study:
- To systematically review the existing evidence on acupuncture and/or moxibustion for cancer-related anorexia.
- To assess the current efficacy of acupuncture as an intervention for appetite loss in cancer patients.
Main Methods:
- Systematic review of current scientific literature.
- Analysis of evidence regarding acupuncture and/or moxibustion interventions.
Main Results:
- Acupuncture has shown effectiveness for other cancer symptoms like nausea.
- The efficacy of acupuncture for cancer-related anorexia is currently unclear.
- Existing evidence is insufficient to definitively conclude benefits for chronic cancer anorexia.
Conclusions:
- More high-quality, large randomized controlled trials are required.
- Further research is needed to establish the role of acupuncture/moxibustion in managing cancer-related appetite problems.
Related Concept Videos
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

